REPORTS

Let’s Pullulate and Expand Your Business

Alzheimer’s Disease Therapeutics and Diagnostics Market - Global Professional Analysis and Forecast to 2026

Apr 02, 2020  |  179 PAGES  |  REPORT CODE: CMM274974
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Alzheimer’s Disease Therapeutics and Diagnostics market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.5% during the forecast period.

This report presents the market size and development trends by detailing the Alzheimer’s Disease Therapeutics and Diagnostics market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Alzheimer’s Disease Therapeutics and Diagnostics market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Alzheimer’s Disease Therapeutics and Diagnostics industry and will help you to build a panoramic view of the industrial development.

Alzheimer’s Disease Therapeutics and Diagnostics Market, By Type:

  • Lumbar puncture test

  • Computed tomography (CT) scan

  • Magnetic resonance imaging (MRI)

  • Electroencephalography (EEG)

  • Positron emission tomography (PET) scan

  • Others

Alzheimer’s Disease Therapeutics and Diagnostics Market, By Application:

  • Marketed Drugs

  • Pipeline Drugs

Some of the leading players are as follows:

  • Forest Laboratories

  • Pfizer

  • H. Lundbeck

  • Novartis

  • AC Immune

  • Eisai

  • Johnson & Johnson.

  • TauRx Therapeutics

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Alzheimer’s Disease Therapeutics and Diagnostics Market: Technology Type Analysis

  • 4.1 Alzheimer’s Disease Therapeutics and Diagnostics Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Alzheimer’s Disease Therapeutics and Diagnostics Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Lumbar puncture test

    • 4.3.2 Computed tomography (CT) scan

    • 4.3.3 Magnetic resonance imaging (MRI)

    • 4.3.4 Electroencephalography (EEG)

    • 4.3.5 Positron emission tomography (PET) scan

    • 4.3.6 Others

5 Alzheimer’s Disease Therapeutics and Diagnostics Market: Product Analysis

  • 5.1 Alzheimer’s Disease Therapeutics and Diagnostics Product Market Share Analysis, 2018 & 2026

  • 5.2 Alzheimer’s Disease Therapeutics and Diagnostics Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Alzheimer’s Disease Therapeutics and Diagnostics Market: Application Analysis

  • 6.1 Alzheimer’s Disease Therapeutics and Diagnostics Application Market Share Analysis, 2018 & 2026

  • 6.2 Alzheimer’s Disease Therapeutics and Diagnostics Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Marketed Drugs

    • 6.3.2 Pipeline Drugs

7 Alzheimer’s Disease Therapeutics and Diagnostics Market: Regional Analysis

  • 7.1 Alzheimer’s Disease Therapeutics and Diagnostics Regional Market Share Analysis, 2018 & 2026

  • 7.2 Alzheimer’s Disease Therapeutics and Diagnostics Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Forest Laboratories

    • 9.1.1 Forest Laboratories Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Pfizer

    • 9.2.1 Pfizer Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 H. Lundbeck

    • 9.3.1 H. Lundbeck Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Novartis

    • 9.4.1 Novartis Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 AC Immune

    • 9.5.1 AC Immune Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Eisai

    • 9.6.1 Eisai Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Johnson & Johnson.

    • 9.7.1 Johnson & Johnson. Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 TauRx Therapeutics

    • 9.8.1 TauRx Therapeutics Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

 

The List of Tables and Figures (Totals 71 Figures and 139 Tables)

  • Figure Lumbar puncture test Alzheimer’s Disease Therapeutics and Diagnostics market, 2015 - 2026 (USD Million)

  • Figure Computed tomography (CT) scan Alzheimer’s Disease Therapeutics and Diagnostics market, 2015 - 2026 (USD Million)

  • Figure Magnetic resonance imaging (MRI) Alzheimer’s Disease Therapeutics and Diagnostics market, 2015 - 2026 (USD Million)

  • Figure Electroencephalography (EEG) Alzheimer’s Disease Therapeutics and Diagnostics market, 2015 - 2026 (USD Million)

  • Figure Positron emission tomography (PET) scan Alzheimer’s Disease Therapeutics and Diagnostics market, 2015 - 2026 (USD Million)

  • Figure Others Alzheimer’s Disease Therapeutics and Diagnostics market, 2015 - 2026 (USD Million)

  • Figure Marketed Drugs market, 2015 - 2026 (USD Million)

  • Figure Pipeline Drugs market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Alzheimer’s Disease Therapeutics and Diagnostics market, by country, 2015 - 2026 (USD Million)

  • Table North America Alzheimer’s Disease Therapeutics and Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table North America Alzheimer’s Disease Therapeutics and Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table North America Alzheimer’s Disease Therapeutics and Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Alzheimer’s Disease Therapeutics and Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Alzheimer’s Disease Therapeutics and Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Alzheimer’s Disease Therapeutics and Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Alzheimer’s Disease Therapeutics and Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Canada Alzheimer’s Disease Therapeutics and Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Canada Alzheimer’s Disease Therapeutics and Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Europe Alzheimer’s Disease Therapeutics and Diagnostics market, by country, 2015 - 2026 (USD Million)

  • Table Europe Alzheimer’s Disease Therapeutics and Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Europe Alzheimer’s Disease Therapeutics and Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Europe Alzheimer’s Disease Therapeutics and Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Alzheimer’s Disease Therapeutics and Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Alzheimer’s Disease Therapeutics and Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Alzheimer’s Disease Therapeutics and Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Alzheimer’s Disease Therapeutics and Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Germany Alzheimer’s Disease Therapeutics and Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Germany Alzheimer’s Disease Therapeutics and Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Alzheimer’s Disease Therapeutics and Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table France Alzheimer’s Disease Therapeutics and Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table France Alzheimer’s Disease Therapeutics and Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Alzheimer’s Disease Therapeutics and Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Italy Alzheimer’s Disease Therapeutics and Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Italy Alzheimer’s Disease Therapeutics and Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Alzheimer’s Disease Therapeutics and Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Spain Alzheimer’s Disease Therapeutics and Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Spain Alzheimer’s Disease Therapeutics and Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Alzheimer’s Disease Therapeutics and Diagnostics market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Alzheimer’s Disease Therapeutics and Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Alzheimer’s Disease Therapeutics and Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Alzheimer’s Disease Therapeutics and Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Alzheimer’s Disease Therapeutics and Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table China Alzheimer’s Disease Therapeutics and Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table China Alzheimer’s Disease Therapeutics and Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Alzheimer’s Disease Therapeutics and Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Japan Alzheimer’s Disease Therapeutics and Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Japan Alzheimer’s Disease Therapeutics and Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Alzheimer’s Disease Therapeutics and Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table India Alzheimer’s Disease Therapeutics and Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table India Alzheimer’s Disease Therapeutics and Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Alzheimer’s Disease Therapeutics and Diagnostics market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Alzheimer’s Disease Therapeutics and Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Alzheimer’s Disease Therapeutics and Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Alzheimer’s Disease Therapeutics and Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Alzheimer’s Disease Therapeutics and Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Alzheimer’s Disease Therapeutics and Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Alzheimer’s Disease Therapeutics and Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Alzheimer’s Disease Therapeutics and Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Alzheimer’s Disease Therapeutics and Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Alzheimer’s Disease Therapeutics and Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Alzheimer’s Disease Therapeutics and Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Alzheimer’s Disease Therapeutics and Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Alzheimer’s Disease Therapeutics and Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table MEA Alzheimer’s Disease Therapeutics and Diagnostics market, by country, 2015 - 2026 (USD Million)

  • Table MEA Alzheimer’s Disease Therapeutics and Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table MEA Alzheimer’s Disease Therapeutics and Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table MEA Alzheimer’s Disease Therapeutics and Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Alzheimer’s Disease Therapeutics and Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Alzheimer’s Disease Therapeutics and Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Alzheimer’s Disease Therapeutics and Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Alzheimer’s Disease Therapeutics and Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Alzheimer’s Disease Therapeutics and Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Alzheimer’s Disease Therapeutics and Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Forest Laboratories Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table H. Lundbeck Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AC Immune Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Eisai Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Johnson & Johnson. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table TauRx Therapeutics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top